Off label and unlicensed prescribing in a specialist oncology center in Australia

This publication has 14 references indexed in Scilit:

• Medicare drug expansion causes controversy in the USA.
  The Lancet, 2009
• The off-label use of drugs in oncology: a position paper by the European Society for Medical Oncology (ESMO)
  Annals of Oncology, 2007
• Off-label prescribing in a French hospital
  International Journal of Clinical Pharmacy, 2006
• Satisfaction with Pharmacotherapy for Approved and Off-Label Indications—A Delphi Study
  Annals of Pharmacotherapy, 2005
• Off licence and off label prescribing in children: litigation fears for physicians
  Archives of Disease in Childhood, 2005
• Off-label prescribing in oncology
  Supportive Care in Cancer, 2004
• Adverse drug reactions and off-label drug use in paediatric outpatients
  British Journal of Clinical Pharmacology, 2002
• Unlicensed and Off-Label Drug Use in an Australian Neonatal Intensive Care Unit
  Pediatrics, 2002
• Prescribing of drugs for use outside their licence in palliative care: survey of specialists in the United Kingdom
  BMJ, 2001
• The Off-Label Debate: A Threat to the Future of Cancer Care
  Cancer Investigation, 1991